Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1999-02-04
2000-09-12
Shippen, Michael L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
A61K 31195
Patent
active
06117906&
ABSTRACT:
A compound of the formula ##STR1## wherein R.sub.1 is a straight or branched alkyl group having from 1 to 6 carbon atoms, phenyl, or cycloalkyl having from 3 to 6 carbon atoms; R.sub.2 is hydrogen or methyl; and R.sub.3 is hydrogen, methyl or carboxyl; which is useful in the treatment of seizure disorders. Processes are disclosed for the preparation of the compound. Intermediates prepared during the synthesis of the compound are also disclosed.
REFERENCES:
patent: 3624102 (1971-11-01), Brown
patent: 3627889 (1971-12-01), Mendham
patent: 3676447 (1972-07-01), Skinner
patent: 3947492 (1976-03-01), Perekalin
patent: 4322440 (1982-03-01), Fish
Andruszkiewicz Ryszard
Franklin Lloyd Charles
Schwindt Mark Alan
Silverman Richard B.
Sobieray Denis Martin
Northwestern University
Shippen Michael L.
Warner-Lambert & Company
LandOfFree
GABA and L-glutamic acid analogs for antiseizure treatment does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with GABA and L-glutamic acid analogs for antiseizure treatment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and GABA and L-glutamic acid analogs for antiseizure treatment will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-96737